Intra-Cellular Therapies Inc
NASDAQ:ITCI
Shareholder Yield
Current shareholder yield for 
OCUL is
-35.97%.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ITCI Price
Intra-Cellular Therapies Inc
| Average Annual Return | 45.72% |
| Standard Deviation of Annual Returns | 36.36% |
| Max Drawdown | -11% |
| Market Capitalization | 14B USD |
| Shares Outstanding | 106 520 000 |
| Percentage of Shares Shorted | 2.54% |
You don't have any saved screeners yet
